This is a Trial Designed to Evaluate the Combination of Nerandomilast With Mycophenolate Across a Wide Variety of Pulmonary Fibrosis Subtypes, With the Aim of Providing Clinicians With Assurance That This is an Appropriate Therapeutic Combination.
Not yet recruitingNCT07570888
University of British ColumbiaInterstitial Lung Disease (ILD), Pulmonary Fibrosis
Start: 2026-06-01End: 2027-07-01Target: 120Updated: 2026-05-11